The risk of pulmonary adverse drug reactions of rebamipide and other drugs for acid‐related diseases: An analysis of the national pharmacovigilance database in South Korea

OBJECTIVE: The objective of this case/non‐case study was to detect rebamipide‐related pulmonary adverse events (AE) compared with other drugs for acid‐related disorders based on population‐level data. METHODS: From 2009 to 2018, AE reports on drugs for acid‐related disorders, which are anatomical th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bo Ram, Lee, Jae‐Young, Kim, Myeong Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304304/
https://www.ncbi.nlm.nih.gov/pubmed/34965009
http://dx.doi.org/10.1111/1751-2980.13075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304304/
https://www.ncbi.nlm.nih.gov/pubmed/34965009
http://dx.doi.org/10.1111/1751-2980.13075

Ejemplares similares